A review on COVID-19 transmission, epidemiological features, prevention and vaccination
Author:
Zhang Yuqin1ORCID, Wu Gonghua1, Chen Shirui1, Ju Xu1, Yimaer Wumitijiang1, Zhang Wangjian1, Lin Shao2, Hao Yuantao13, Gu Jing1, Li Jinghua1
Affiliation:
1. School of Public Health, Sun Yat-Sen University , Guangzhou , China 2. Department of Environmental Health Sciences , School of Public Health, University at Albany, State University of New York , Rensselaer , NY , USA 3. Sun Yat-Sen University Global Health Institute, School of Public Health and Institute of State Governance, Sun Yat-Sen University , Guangzhou , China
Abstract
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections and millions of deaths over past two years. Currently, many countries have still not been able to take the pandemic under control. In this review, we systematically summarized what we have done to mitigate the COVID-19 pandemic, from the perspectives of virus transmission, public health control measures, to the development and vaccination of COVID-19 vaccines. As a virus most likely coming from bats, the SARS-CoV-2 may transmit among people via airborne, faecal-oral, vertical or foodborne routes. Our meta-analysis suggested that the R0 of COVID-19 was 2.9 (95% CI: 2.7–3.1), and the estimates in Africa and Europe could be higher. The median Rt could decrease by 23–96% following the nonpharmacological interventions, including lockdown, isolation, social distance, and face mask, etc. Comprehensive intervention and lockdown were the most effective measures to control the pandemic. According to the pooled R0 in our meta-analysis, there should be at least 93.3% (95% CI: 89.9–96.2%) people being vaccinated around the world. Limited amount of vaccines and the inequity issues in vaccine allocation call for more international cooperation to achieve the anti-epidemic goals and vaccination fairness.
Publisher
Walter de Gruyter GmbH
Reference180 articles.
1. Peeri, NC, Shrestha, N, Rahman, MS, Zaki, R, Tan, Z, Bibi, S, et al.. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 2020;49:717–26. https://doi.org/10.1093/ije/dyaa033. 2. International Expert Meeting on the Treatment of SbTCM, the Integration of Traditional Chinese Medicine with Western M. SARS: clinical trials on treatment using a combination of traditional Chinese medicine and Western medicine: report of the WHO International Expert Meeting to review and analyse clinical reports on combination treatment for SARS, 8–10 October 2003. Beijing, People’s Republic of China. In. Geneva: World Health Organization; 2004. 3. WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). Available from: https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers#tab=tab_1 [Accessed 4 Apr 2021]. 4. Al-Omari, A, Rabaan, AA, Salih, S, Al-Tawfiq, JA, Memish, ZA. MERS coronavirus outbreak: implications for emerging viral infections. Diagn Microbiol Infect Dis 2019;93:265–85. https://doi.org/10.1016/j.diagmicrobio.2018.10.011. 5. Zhu, N, Zhang, D, Wang, W, Li, X, Yang, B, Song, J, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33. https://doi.org/10.1056/nejmoa2001017.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|